The largest database of trusted experimental protocols

Apoptosis detection kit

Manufactured by Genview
Sourced in United States

The Apoptosis Detection Kit is a laboratory tool designed to detect and analyze apoptosis, a form of programmed cell death. It provides a reliable method for identifying and quantifying apoptotic cells through the measurement of specific biochemical markers associated with the apoptotic process.

Automatically generated - may contain errors

3 protocols using apoptosis detection kit

1

Targeted delivery of temozolomide

Check if the same lab product or an alternative is used in the 5 most similar protocols
Polyethyleneimine (PEI, 10 kDa) was obtained from Sigma. HOOC-PEG (2000)-Angiopep-2 was purchased from Guangzhou Carbon Water Technology Co., Ltd. Temozolomide was obtained from Aladdin Industrial Corporation. EDC and NHS were obtained from Aladdin Industrial Corporation. The primary anti-CD47 antibody and the secondary HRP Goat anti-rabbit IgG antibodies were obtained from ABclonal Technology Co., Ltd. The anti-EGFR antibody was obtained from abcam (ab214627). Fetal bovine serum (FBS) was purchased from Life Technologies. The Apoptosis Detection Kit was purchased from Genview. PKH26 and PKH67 were obtained from Umibio Science and Technology.
+ Open protocol
+ Expand
2

Transferrin-Targeted Nanotherapeutics for Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELE was purchased from Dalian Huali Jingang Pharmaceutical Co. Ltd (Dalian, China). CTX was purchased from Hubei Qianmo biological technology Co. Ltd (Hubei, China). Soya lecithin (the main ingredient is phosphatidylcholine, PC) was purchased from Shanghai Taiwei pharmaceutical Co. Ltd (Shanghai, China). d-α-tocopherol polyethylene glycol succinate (TPGS) was purchased from Wuhan Guobangda pharmaceutical chemical Co. Ltd (Wuhan, China). Medium chain triglyceride (MCT) was purchased from Xinxing Tieling pharmaceutical Co. Ltd (Tieling, China). Cholesterol (Chol) was purchased from Beijing Dingguo Changsheng Biotechnology Co. Ltd (Beijing, China). DSPE-PEG2000-transferrin was purchased from Xi’an Ruixi Biological Technology Co. Ltd (Xi’an, China). DAPI and GAPDH were purchased from Sigma-Aldrich (St Louis, USA). Penicillin–streptomycin and high-glucose DMEM, trypsin EDTA and FBS were purchased from Gibco Life Technologies (AG, USA). CCK-8 was purchased from Meilunbio (Dalian, China). Cypate was purchased from Hangzhou Xinqiao Biotechnology Co. LTD (Hangzhou, China). Coomassie blue, RIPA lysis buffer and bicinchoninic acid protein kit (BCA) were purchased from Biosharp (Shanghai, China). Apoptosis detection kit was purchased from Genview (USA).
+ Open protocol
+ Expand
3

Cytotoxicity and Apoptosis Evaluation of Targeted Lipid Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytotoxicity effects of ELE/CTX@LIP, ELE/CTX@BLIP, Tf-ELE/CTX@LIP and Tf-ELE/CTX@BLIP on RG2 cells were determined using a CCK-8 kit. RG2 cells (3000 cells/well) were inoculated in 96-well plates and incubated for 24 h. After incubation, cells were exposed to ELE/CTX@LIP, ELE/CTX@BLIP, Tf-ELE/CTX@LIP and Tf-ELE/CTX@BLIP (CTX concentrations ranging from 0.4 to 200 ng/mL) for 48 h. Non-treated cells were used as negative controls. Medium was evaluated as the blank control. Cytotoxicity was quantitatively determined by measuring the absorbance at 450 nm using a Spark multi-functional microporous plate testing platform (Tecan, Switzerland).
Furthermore, apoptotic cells were determined by FACS analysis (CytoFLEX S, USA). RG2 cells were incubated with ELE/CTX@LIP, ELE/CTX@BLIP, Tf-ELE/CTX@LIP and Tf-ELE/CTX@BLIP and 50 ng/mL CTX for 48 h then treated with the apoptosis detection kit (Genview, USA) for 10 min. Percentage of apoptotic cells was determined using a FACS Calibur System. Non-treated cells were used as the negative control [46 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!